Skip to main content
Signal8
Brooks Gabriel profile photo

Gabriel Brooks

CIK: 0001997809

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (35.0%)

Position reduction

Option Exercises (M)7 (35.0%)

Derivative conversions

Awards (A)6 (30.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Solid Biosciences Inc. logo
SLDB

Solid Biosciences Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (20 total)

  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Oct 19, 2026
    Sale(S)
    Direct
    4.4K shares at avg. $5.62$25K
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Oct 18, 2026
    Exercise(M)
    Direct
    9.8K shares-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Feb 18, 2026
    Sale(S)
    Direct
    0 shares at avg. $5.82-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Feb 13, 2026
    Exercise(M)
    Direct
    10.9K shares-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Feb 4, 2026
    Sale(S)
    Direct
    12.6K shares at avg. $6.44$81K
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Feb 2, 2026
    Sale(S)
    Direct
    28.3K shares at avg. $6.44$182K
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Jan 31, 2026
    Exercise(M)
    Direct
    28.2K shares-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Jan 29, 2026
    Award(A)

    Restricted Stock Units

    Direct
    58.8K shares-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Jan 29, 2026
    Award(A)

    Restricted Stock Units

    Direct
    103.8K shares-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Jan 29, 2026
    Exercise(M)
    Direct
    58.8K shares-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Jan 29, 2026
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    207.5K shares-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Oct 20, 2025
    Sale(S)
    Direct
    2.9K shares at avg. $5.96$17K
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Oct 18, 2025
    Exercise(M)
    Direct
    9.8K shares-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Aug 14, 2025
    Award(A)

    Restricted Stock Units

    Direct
    71.3K shares-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Aug 14, 2025
    Award(A)

    Employee Stock Option (Right to Buy)

    Direct
    142.5K shares-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Feb 14, 2025
    Sale(S)
    Direct
    3.3K shares at avg. $3.96$13K
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Feb 13, 2025
    Exercise(M)
    Direct
    10.9K shares-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Jan 31, 2025
    Award(A)

    Restricted Stock Units

    Direct
    112.9K shares-
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Oct 21, 2024
    Sale(S)
    Direct
    2.9K shares at avg. $6.50$19K
  • Solid Biosciences Inc. logo
    SLDB

    Solid Biosciences Inc.

    Oct 18, 2024
    Exercise(M)
    Direct
    9.8K shares-

1-20 of 20

About Brooks Gabriel

Brooks Gabriel (SEC CIK 0001997809) files insider reports with the SEC as Chief Medical Officer of Solid Biosciences Inc. (SLDB).

Signal8 holds 10 ownership filings by Brooks Gabriel, all Form 4s, filed between Oct 22, 2024 and Oct 20, 2026. Those filings report 20 transactions, from Oct 18, 2024 to Oct 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Brooks Gabriel's filings is in CHARLESTOWN, MA.

Recent filings by Brooks Gabriel

  • Oct 19, 2026: Open-market sale of SLDB shares (Form 4, code S).
  • Oct 18, 2026: Option exercise of SLDB shares (Form 4, code M).
  • Feb 18, 2026: Open-market sale of SLDB shares (Form 4, code S).
  • Feb 13, 2026: Option exercise of SLDB shares (Form 4, code M).
  • Feb 4, 2026: Open-market sale of SLDB shares (Form 4, code S).

Other insiders filing for Solid Biosciences Inc. (SLDB)

How to read Form 4 transaction codes